Joint Technical Committee Sample Clauses

Joint Technical Committee a. The Government of the Republic of Sudan and the Government of the Republic of South Sudan shall establish a Joint Technical Committee, the mandate of which shall be to ensure the calculation of the Post-Service Benefits, including gratuities and pensions, for each person eligible for payment under this Agreement on Friendly Relations & Cooperation. This Joint Technical Committee shall be made up of equal numbers of officials from the Government of the Republic of South Sudan and the Government of the Republic of Sudan. b. The Government of the Republic of South Sudan and the Government of the Republic of Sudan shall provide, in a timely manner, any information, which the Committee deems necessary to facilitate the calculation of the Post-Service Benefits. Calculation of Post-Service Benefits for Eligible Pensioners for payment under this Agreement on Friendly Relations & Cooperation shall be carried out in accordance with the Republic of Sudan Public Service Pensions Act, 1992, as amended 2004, and the Republic of Sudan National Civil Service Regulations, 2007 and any other relevant Sudanese laws or regulations. c. Within sixty (60) days of the signature of this Agreement on Friendly Relations & Cooperation, both Parties shall jointly engage an independent third party (International Labour Organisation) to determine modality for the resumption and future payment to the Eligible Pensioners. The Government of the Republic of South Sudan, the Government of the Republic of Sudan and the Joint Technical Committee, shall make available to the designated third-party all records and documents requested by the Joint Technical Committee, as well as other documents deemed necessary and requested by either of the governments or the independent third party.
Sample 1Sample 2
AutoNDA by SimpleDocs
Joint Technical Committee. [Summary] AU to provide surveyors to assist the Joint Technical Committee. Page 5, Part lll, institutions Relating to Demarcation
Sample 1Sample 2
Joint Technical Committee. The parties subscribe to the principle of equal pay for work of equal value. The parties will continue a Joint Technical Committee to review and update the Joint Job Evaluation Plan (JJEP) and distribute the low wage redress funds following the criteria in Appendix A1 to close the wage gap with comparator classifications in the Health Sector, while maintaining the integrity of the JJEP classification system. It will provide recommendations on how to apply the available low wage redress funds in each year of the collective agreement.
Sample 1Sample 2
Joint Technical Committee. The term ‘‘joint technical committee’’ means the joint technical committee estab- lished by the Agreement.
Sample 1Sample 2
Joint Technical Committee. (a) COMPOSITION Promptly following the Effective Date, Kinetek and QLT shall establish a Joint Technical Committee to review and co-ordinate the parties' efforts under the Research Program. The JTC shall consist of an equal number of representatives from each party (which number may be increased or decreased upon recommendation of the JMC from time to time). Each of Kinetek and QLT may change its representatives from time to time by written notice to the other. (b) FUNCTIONS The JTC shall have the following functions: (i) to prepare the draft Research Program budget; (ii) to prepare and recommend to the JMC the draft Research Plan including project progression criteria, and any proposed revisions thereto; (iii) to select Research Candidates and the Fields or indications in which they may be pursued; (iv) to receive and review reports by Kinetek; (v) to review Compounds and Targets identified by Kinetek; (vi) to regularly review the progress of the Research Program in respect of each Research Candidate; (vii) to maintain the quality of data and reports; (viii) to supervise Patent prosecution and maintenance by the parties; (ix) to discuss matters relating to Patents as may be presented to the JTC by Kinetek or QLT; (x) to ensure proper transition of the research in respect of a Lead Compound from Kinetek to QLT following the exercise by QLT of the Development Election in respect of that Lead Compound; (xi) to make recommendations to the JMC on all aspects of the Research Program; and (xii) to undertake such other responsibilities and functions as may be assigned to it by the JMC; (c) CHAIR Unless the parties otherwise agree, Kinetek shall appoint the first chair of the JTC from among the members of the JTC. The Chair shall alternate at each meeting between the appointee of Kinetek and QLT. (d) MEETINGS The JTC shall meet a minimum of 8 times per year and at least once per calendar quarter, or as otherwise determined by the JTC, and shall establish its own rules for the conduct of its meetings. All meetings shall be in person and in Vancouver, the precise location to be mutually agreed by the parties, or by teleconference. Quorum for meetings shall be an equal number of each party's representatives.
Sample 1
Joint Technical Committee. The Joint Technical Committee to be formed shall consist of the following representatives from FLEX, OCLI and SICPA. As representatives of OCLI: XXXXX X. XXXXXX XXXXXX X. XXXXXX XXXXXXX X. XXXX As representatives of SICPA: ANTON BLEIKOLM XXXXXX X. XXXXXXXXX As representatives of FLEX: XXXXXXX XXXXXXXX XXXXXXX XXXXXXX XXXXX XXXXXXXX
Sample 1
Joint Technical Committee. Promptly after the Effective Date, the Parties shall establish a joint technical committee (the “Joint Technical Committee” or “JTC”) to oversee, review and coordinate day-to-day work under the Work Plans. The JTC shall exist until completion of the Development Phase. The JTC shall be responsible for: (a) reviewing, coordinating and monitoring the activities and progress of the Parties in implementing the Work Plans, and ensuring each Party’s compliance therewith; (b) establishing the goals and priorities for the activities under the Work Plans; and (c) performing such other functions as are specifically designated for the JTC in this Agreement or otherwise as agreed by the Parties.
Sample 1
AutoNDA by SimpleDocs
Joint Technical Committee. The parties shall establish a Joint Technical Committee ("JTC"). So long as CIBA holds an exclusive license under this Agreement, the JTC shall have responsibility for coordination, review and approval of Product development efforts, clinical trials, regulatory submissions and selection and retention of any third party consultants. The JTC shall specifically approve all clinical protocols, selection and training of participating surgeons, evaluate the outcomes of all clinical trials, determine the significance of such outcomes and make the final decision regarding when and whether to seek Product Registrations in any country within the Territory. The JTC shall also approve the sale of any Products in countries for which a Product Registration is not required by law and determine whether any of the Patent Rights should be permitted to lapse or become abandoned. (a) The parties shall each appoint 2 voting members to serve on the JTC. All approvals, determinations or other actions by the JTC shall require the affirmative votes of at least 3 of the 4 members. In the event of a deadlock on any issue requiring a vote of the JTC, such issue shall be referred to the respective Executive Officers of each party for resolution by good faith negotiations. (b) The JTC shall maintain minutes of meetings signed by all voting members, which record the items presented for consideration by the JTC and the outcome of all votes or other actions taken. Copies of such minutes shall be provided to all voting members. All files, documents or other records created or maintained by or behalf of the JTC shall be available to both parties upon request, subject to the terms of Section 11. (c) The JTC will meet periodically and as required, but no less frequently than once every six (6) months, unless otherwise mutually agreed by the parties. The JTC will meet within ten (10) business days following the request of either party. Such meetings may be held either in person or via any telecommunications medium acceptable to the parties. Each party shall bear its own personnel, travel, lodging, and other expenses relating to JTC meetings. Either party may change one or more of its representatives to the JTC at any time. Members of the JTC may be represented at any meeting by another member of the JTC, or by a deputy. Either party may permit additional employees to attend and participate (on a non-voting basis) in the JTC meetings. Consultants or other third parties shall also be permitted t...
Sample 1

Related to Joint Technical Committee

  • Technical Committee 1. The Technical Committee shall comprise: (a) nine experts representing different regions of the Agreement Area, in accordance with a balanced geographical distribution; (b) one representative from the International Union for Conservation of Nature and Natural Resources (IUCN), one from the International Waterfowl and Wetlands Research Bureau (IWRB) and one from the International Council for Game and Wildlife Conservation (CIC); and (c) one expert from each of the following fields: rural economics, game management, and environmental law. The procedure for the appointment of the experts, the term of their appointment and the procedure for designation of the Chairman of the Technical Committee shall be determined by the Meeting of the Parties. The Chairman may admit a maximum of four observers from specialized international inter- governmental and non-governmental organizations. 2. Unless the Meeting of the Parties decides otherwise, meetings of the Technical Committee shall be convened by the Agreement secretariat in conjunction with each ordinary session of the Meeting of the Parties and at least once between ordinary sessions of the Meeting of the Parties. 3. The Technical Committee shall: (a) provide scientific and technical advice and information to the Meeting of the Parties and, through the Agreement secretariat, to Parties; (b) make recommendations to the Meeting of the Parties concerning the Action Plan, implementation of the Agreement and further research to be carried out; (c) prepare for each ordinary session of the Meeting of the Parties a report on its activities, which shall be submitted to the Agreement secretariat not less than one hundred and twenty days before the session of the Meeting of the Parties, and copies shall be circulated forthwith by the Agreement secretariat to the Parties; and (d) carry out any other tasks referred to it by the Meeting of the Parties. 4. Where in the opinion of the Technical Committee there has arisen an emergency which requires the adoption of immediate measures to avoid deterioration of the conservation status of one or more migratory waterbird species, the Technical Committee may request the Agreement secretariat to convene urgently a meeting of the Parties concerned. These Parties shall meet as soon as possible thereafter to establish rapidly a mechanism to give protection to the species identified as being subject to particularly adverse threat. Where a recommendation has been adopted at such a meeting, the Parties concerned shall inform each other and the Agreement secretariat of measures they have taken to implement it, or of the reasons why the recommendation could not be implemented. 5. The Technical Committee may establish such working groups as may be necessary to deal with specific tasks.

  • Joint Research Committee The Parties hereby establish a committee to facilitate the Research Program as follows:

  • Joint Development Committee (a) The Parties shall establish a Joint Development Committee (the “Joint Development Committee” or “JDC”), comprised of [**] representatives of Ikaria and [**] representatives of BioLineRx, to oversee the Development of Products. Each Party shall make its initial designation of its representatives not later than [**] days after the Effective Date. Each Party may change any one or more of its representatives to the Joint Development Committee at any time upon notice to the other Party. (b) The JDC shall meet at least [**] during the Development Term or more or less frequently as the JDC may agree. The JDC may meet in person or by means of a telephone or video conference call. One meeting of the JDC per year shall be held in person at Ikaria’s headquarters in Clinton, NJ and one meeting of the JDC per year shall be held in person at BioLineRx’s headquarters in Israel, provided, that the Parties’ representatives may participate in person, via telephone, or video conference in their discretion. Each Party shall use reasonable efforts to cause its representatives to attend the meetings of the JDC. If a representative of a Party is unable to attend a meeting, such Party may designate an alternate to attend such meeting in place of the absent representative. Each Party shall bear its own costs with respect to its participation on the JDC. Prior to every meeting of the JDC, Ikaria will provide to the JDC detailed reports describing Ikaria’s current clinical and development activities and plans. (c) The JDC shall be the vehicle by which BioLineRx may offer insight and guidance to Ikaria with respect to (i) establishing the Development Plan setting forth the Development Program’s objectives and the activities to be conducted, (ii) reviewing and updating the Development Plan from time to time, (iii) monitoring the progress and results of the Development Program, (iv) determining future Development Program activities, including Development activities relating to Manufacturing, to be conducted during the Development Term, and (v) establishing success criteria for the clinical trials (other than those for which success criteria are set forth in this Agreement), and determining whether the results of such clinical trials have achieved the applicable success criteria. (d) The JDC shall only act unanimously, with each Party given one (1) vote regardless of the number of representatives. If, however, the JDC is unable to reach agreement with respect to any matter within [**] days, the matter shall be referred to the Parties’ respective Executive Officers for resolution. If the Executive Officers are not able to resolve any such matter by consensus within [**] days following referral, Ikaria’s Executive Officer shall have the right to decide the matter taking into account Ikaria’s obligation to use Commercially Reasonable Efforts under Section 3.8. Notwithstanding anything in this Section 3.2, neither Party shall have a unilateral right to resolve any dispute involving the breach or alleged breach of this Agreement, to amend or modify this Agreement or the Parties’ respective rights and obligations hereunder or, except as expressly provided in this Section 3.2, any Development Plan or the Parties’ respective rights and obligations thereunder.

  • Joint Steering Committee Promptly after the Effective Date, the Parties will form a Joint Steering Committee (the “JSC”) composed of an equal number of employees of each of Curis and Genentech, but in no event to exceed four (4) members from each Party. The JSC shall determine the specific goals for the Collaboration, shall manage the ongoing research conducted under the Collaboration in accordance with the Research Plan, shall monitor the progress and results of such work, and shall oversee and coordinate the development and commercialization of Compounds (other than Collaboration Products); provided, however, that the JSC shall not have decision-making authority with respect to the development and commercialization of Collaboration Products, which shall be governed by the CSC. The presence of at least one (1) representative of each Party shall constitute a quorum for the conduct of any JSC meeting. All decisions of the JSC shall require unanimous approval, with the representatives of each Party collectively having one (1) vote, provided in the event of a deadlock, the issue shall be referred to the Chief Executive Officer of Curis and the Senior Vice President of Research of Genentech, or their respective designees, who shall promptly meet and attempt in good faith to resolve such issue within thirty (30) days. If such executives cannot resolve such matter, then Genentech shall have final decision-making authority with regard to decisions regarding the Collaboration (including, without limitation, the JSC’s designation of a Compound as either a Lead Product or Excluded Product); provided, however, that in no event shall Genentech have the right or power to take any of the following actions without the approval of Curis’ representatives on the JSC: (a) approve the initial Research Plan (an outline of which has been agreed upon by the Parties as of the Effective Date); (b) amend or modify this Agreement or the Research Plan; (c) resolve any such matter in a manner that conflicts with the provisions of this Agreement (including, without limitation, the Research Plan); (d) make any decision with respect to the development or commercialization of Curis Products; or (e) make any decision with respect to the prosecution, maintenance, defense or enforcement of any Curis Patents. The JSC shall meet at such frequency as the JSC agrees, except that, until the filing of the first IND for a Lead Product utilizing Systemic Delivery in a Major Market, the JSC shall meet on at least a quarterly basis. Meetings of the JSC, and JSC dispute resolution meetings between Curis’ Chief Executive Officer and Genentech’s Senior Vice President of Research (or their designees), may be conducted by videoconference, teleconference or in person, as agreed by the Parties, and the Parties shall agree upon the time and place of meetings. A reasonable number of additional representatives of a Party may attend meetings of the JSC in a non-voting capacity. The JSC shall exist for so long as either any work is being conducted under the Research Plan or any Compound is being developed or commercialized by Genentech, Curis, or any of their respective Affiliate(s) or sublicensee(s) in any Major Market. The JSC shall also be responsible for designating one or more representatives of each Party with expertise in patent law (which individuals need not be members of the JSC) to oversee intellectual property matters relating to the Collaboration, subject to the provisions of Article 10, and such patent committee shall coordinate with and report to the JSC.

  • Joint Commercialization Committee As of the Effective Date, the Parties have established a joint commercialization committee (the “Joint Commercialization Committee” or the “JCC”), composed of up to [ * ] representatives of each Party, to monitor and discuss the Commercialization of Products at the operational level. Each JCC representative shall have knowledge and expertise in the commercialization of products similar to Products. The JCC shall in particular: (a) review and recommend the Commercialization Plans and related activities with respect to the Commercialization of Products in the Collaborator Territory, and report to the JEC on all significant Commercialization activities in the Collaborator Territory; (b) provide a forum for and facilitate communications and coordination between the Parties with respect to the Commercialization of Products in the Collaborator Territory and the Exelixis Territory; (c) on an annual basis, discuss and establish Collaborator’s Minimum Commercial Performance thresholds pursuant to Section 6.3(b) and propose recommendation to JEC; [ * ] = Certain confidential information contained in this document, marked by brackets, has been omitted and filed separately with the Securities and Exchange Commission pursuant to Rule 24b-2 of the Securities Exchange Act of 1934, as amended. (d) review the status of material Product manufacturing and supply activities and strategies associated with Commercialization; (e) review and discuss the major findings of Collaborator’s market research with respect to any Product in the Collaborator Territory, if any; (f) review and oversee the branding and product positioning strategy for Products in the Collaborator Territory and evaluate Collaborator’s brand strategy for the Product in the Collaborator Territory for consistency with the then-current global brand strategy for the Product; (g) discuss Product list price and status of reimbursement in the Collaborator Territory; and (h) perform such other functions as may be appropriate to further the purposes of this Agreement with respect to the Commercialization of Products, including endeavoring to resolve any disputes between the Parties arising from the deliberations of the JCC, or as otherwise directed by the JEC.

  • Development Committee Arcadia and Xxxxxx shall establish a development committee (the “Development Committee”) comprised of no more than three (3) representatives of each of Arcadia and Xxxxxx. The Development Committee shall be chaired by a member thereof designated from time to time by Arcadia. The Development Committee shall oversee the Research Plan, Milestones and development and production of plants and microorganisms that produce Transgenic Oil in accordance with the Research Plan. The Development Committee may revise the Research Plan and the Milestones as deemed necessary and appropriate by unanimous written consent of all members. Meetings of the Development Committee shall be at least biannual and at such times and places or in such form (e.g., in person, telephonic or video conference) as the members of the Development Committee shall determine. Representatives of both Parties shall be present at any meeting of the Development Committee. Decisions of the Development Committee shall be made by a written consent signed by all six (6) members thereof. The Development Committee shall keep minutes of its deliberations setting forth, among other matters, all proposed actions and all votes thereon. All records of the Development Committee shall at all times be available to both Parties. The Development Committee by unanimous consent may delegate to one Party or to a specific representative the authority to make certain decisions. The Development Committee may revoke such authority by the written consent of four members. All disagreements within the Development Committee shall be subject to the following: (i) The members of the committee will endeavor in good faith for a period of not more than ninety (90) days to attempt to resolve the disagreement; (ii) If the members of the committee are unable to resolve the disagreement by the end of such period, the committee shall promptly present the disagreement to the President of Xxxx Products Division and the President of Arcadia or their respective designees, and the two executives shall endeavor to resolve the disagreement for a period of not more than thirty (30) days; (iii) If the two executives are unable to resolve this disagreement, the disagreement shall be submitted for ADR as provided in Section 12(a).

  • Steering Committee A. CIFNAL/ICBFN shall be managed by a Steering Committee comprised of elected representatives from the membership. B. The Steering Committee is empowered to conduct the business of CIFNAL/ICBFN in accordance with the recommendations of the membership; approve and enact project activities; discuss and recommend future policy or changes in policy to be adopted by the membership; make budgetary decisions for CIFNAL/ICBFN; approach funding agencies; conduct periodic membership drives; and maintain communication with scholarly and professional associations as well as with other, similar cooperative projects. C. The Steering Committee shall consist of at least five representatives of CIFNAL/ICBFN. 1. Four representatives shall be elected to at-large positions on the Steering Committee in accordance with the procedures in Section VIII. At least one representative shall be from a French or francophone institution. 2. The Chair of CIFNAL/ICBFN shall chair the Steering Committee. 3. Elected Coordinators of standing Working Groups shall serve on the Steering Committee for the period of their elected terms. 4. A representative of CRL shall serve as an ex officio member of the Steering Committee. D. An advisory group of scholars and end-users, including representatives from academic organizations concerned with library and scholarly issues in francophone studies as well as non-academic information users and providers, shall be appointed by the Steering Committee as appropriate. The makeup of the advisory group shall be formulated to provide a balance of opinion and diversity of expertise. Members of the advisory group need not be from institutions that are a member of CIFNAL/ICBFN, and shall serve as ex officio members of the Steering Committee. E. All elected representatives on the Steering Committee, including the Chair, shall have equal votes on matters requiring a formal approval by the Committee. Each member shall be accorded one vote. Ex officio members shall be non-voting members. F. Steering Committee Members shall serve three-year terms, with staggered elections; re- election is permitted for one additional term. Elected members begin their term of office immediately following the annual membership meeting. G. In the event a member is unable to serve a full term, the Chair shall appoint a replacement to serve the remainder of the term. Following this period, the replacement shall be eligible to stand for election according to the terms of Section V.

  • Joint Technology The Parties agree that, in order to effectuate the provisions of Section 4.4.2, subject to any exclusive licenses granted hereunder, (a) the non-use provisions of this Article 9 shall not apply to each Party’s use of Joint Technology, and (b) each Party may disclose the Joint Technology to Third Parties who are under terms of confidentiality no less strict than those contained in this Agreement.

  • Joint Inventions For Subject Inventions conceived or first actually reduced to practice under this Agreement that are joint Subject Inventions made by CONTRACTOR and USER, each Party shall have the option to elect and retain title to its undivided rights in such joint Subject Inventions.

  • Collaboration 31.1 If the Buyer has specified in the Order Form that it requires the Supplier to enter into a Collaboration Agreement, the Supplier must give the Buyer an executed Collaboration Agreement before the Start date. 31.2 In addition to any obligations under the Collaboration Agreement, the Supplier must: 31.2.1 work proactively and in good faith with each of the Buyer’s contractors 31.2.2 co-operate and share information with the Buyer’s contractors to enable the efficient operation of the Buyer’s ICT services and G-Cloud Services

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!